Evidence map›Paper›PMID 39937728›Full record

ArticlePloS one2025

X under Musk's leadership: Substantial hate and no reduction in inauthentic activity.

Daniel Hickey, Daniel M T Fessler, Kristina Lerman, Keith Burghardt

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Daniel HickeySchool of Information, University of California, Berkeley, Berkeley, California, United States of America.ORCID 0009-0006-5577-0063
Daniel M T FesslerDepartment of Anthropology and UCLA Bedari Kindness Institute, University of California, Los Angeles, Los Angeles, California, United States of America.
Kristina LermanUSC Information Sciences Institute, Marina del Rey, California, United States of America.
Keith BurghardtUSC Information Sciences Institute, Marina del Rey, California, United States of America.ORCID 0000-0003-1164-9545

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Numerous studies have reported an increase in hate speech on X (formerly Twitter) in the months immediately following Elon Musk's acquisition of the platform on October 27th, 2022; relatedly, despite Musk's pledge to "defeat the spam bots," a recent study reported no substantial change in the concentration of inauthentic accounts. However, it is not known whether any of these trends endured. We address this by examining material posted on X from the beginning of 2022 through June 2023, the period that includes Musk's full tenure as CEO. We find that the increase in hate speech just before Musk bought X persisted until at least May of 2023, with the weekly rate of hate speech being approximately 50% higher than the months preceding his purchase, although this increase cannot be directly attributed to any policy at X. The increase is seen across multiple dimensions of hate, including racism, homophobia, and transphobia. Moreover, there is a doubling of hate post "likes," indicating increased engagement with hate posts. In addition to measuring hate speech, we also measure the presence of inauthentic accounts on the platform; these accounts are often used in spam and malicious information campaigns. We find no reduction (and a possible increase) in activity by these users after Musk purchased X, which could point to further negative outcomes, such as the potential for scams, interference in elections, or harm to public health campaigns. Overall, the long-term increase in hate speech, and the prevalence of potentially inauthentic accounts, are concerning, as these factors can undermine safe and democratic online environments, and increase the risk of offline harms.

Indexed as

HateLeadershipSocial MediaFatty Acids, MonounsaturatedHumansFatty Acids, Monounsaturatedmusk

Identifiers

PMID39937728
PMCPMC11819532

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.